Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved the government funding status banner from the page. The change does not affect the presentation of the study details or other core content.SummaryDifference0.4%

- Check47 days agoChange DetectedThe new screenshots show minor UI and layout updates with no impact on core study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedUpdates the page to v3.2.0 with a government-funding status notice for the NIH Clinical Center and links for current operating status; removes the previous v3.1.0 revision.SummaryDifference4%

- Check77 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, updating the page revision/version.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoved three core topics (Electromagnetic Radiation, Magnetic Phenomena, and Electromagnetic Phenomena) from the page; this substantially narrows or changes the page’s subject matter without replacing them with new content.SummaryDifference0.3%

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.